earnings
confidence high
sentiment positive
materiality 0.85
Delcath reports FY2025 revenue $85.2M, net income $2.7M; guides FY2026 revenue ≥$100M
DELCATH SYSTEMS, INC.
2025-FY EPS
reported $0.07
vs consensus -$0.06
▲ beat
(+211.3%)
- FY2025 total revenue $85.2M, up 129% YoY ($37.2M); HEPZATO revenue $78.8M, CHEMOSAT $6.4M.
- Full-year net income $2.7M vs net loss $26.4M in 2024; adjusted EBITDA $25.1M.
- Cash $91.0M, no debt; repurchased 628,572 shares for $6.0M.
- FY2026 guidance: total revenue at least $100M, HEPZATO volume growth ≥20%, gross margin 84-87%.
- 28 active centers; 140% procedure volume growth in 2025; publications including CHOPIN study.